ArticleFrontiers in pharmacology2021

Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo.

Gangyang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.